Also trades as: ACW.AX (ASX) · $vol 0M
ATGGF OTC
Actinogen Medical Limited
1W: +71.4%
1M: +71.4%
3M: +7400.0%
YTD: +50.0%
1Y: +140.0%
3Y: +150.0%
5Y: +71.4%
$0.06
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$419K
-107.6% ▼
Operating Income
-$28M
-88.0% ▼
Net Income
-$15M
-4.2% ▼
EPS (Diluted)
$-0.00
+6.1% ▲
EBITDA
-$28M
-84.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4M | $5M | $10M | $5M | $0 |
| YoY Growth | +83.5% | +34.3% | +103.2% | -44.7% | -100.0% |
| Cost of Revenue | $401K | $406K | $0 | $0 | $419K |
| Gross Profit | $3M | $4M | $10M | $5M | -$419K |
| Gross Margin | 89.0% | 91.7% | 100.0% | 100.0% | — |
| R&D Expenses | $8M | $9M | $16M | $12M | $19M |
| SG&A Expenses | $5M | $7M | $7M | $8M | $9M |
| Operating Expenses | $13M | $15M | $23M | $20M | $28M |
| Operating Income | -$9M | -$11M | -$13M | -$15M | -$28M |
| Operating Margin | -250.9% | -216.4% | -129.3% | -272.0% | — |
| Interest Expense | $18K | $17K | $24K | $0 | $465K |
| Income Before Tax | -$9M | -$11M | -$23M | -$15M | -$28M |
| Tax Expense | $0 | $0 | -$10M | $0 | -$13M |
| Net Income | -$9M | -$11M | -$13M | -$15M | -$15M |
| Net Margin | -260.9% | -220.0% | -131.3% | -268.4% | — |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | -$13M | -$15M | -$13M | -$15M | -$28M |
| Shares Outstanding | 1.79B | 1.88B | 2.17B | 2.98B | 3.33B |